Cyanotech Initiates Trial of BioAstin Effect on Human Cholesterol Levels.Business Editors & Health/Medical Writers KAILUA-KONA, Hawaii--(BW HealthWire)--June 28, 2001 Cyanotech Corporation (Nasdaq NMS See NetWare Management System. : CYAN), the world leader in producing high-value, natural products from microalgae, has initiated a new clinical trial of BioAstin(R) to measure its effectiveness in reducing LDL LDL - ["LDL: A Logic-Based Data-Language", S. Tsur et al, Proc VLDB 1986, Kyoto Japan, Aug 1986, pp.33-41]. (bad) cholesterol while increasing HDL (Hardware Description Language) A language used to describe the functions of an electronic circuit for documentation, simulation or logic synthesis (or all three). Although many proprietary HDLs have been developed, Verilog and VHDL are the major standards. (good) cholesterol. The study will also test whether BioAstin can beneficially alter other serum markers in a double blind, placebo-controlled trial with human subjects. The clinical trial is being conducted with 44 patients and is being coordinated by Dr. Gene Spiller at the Health Research Studies Center in Los Altos, California Los Altos (IPA: [lɔs ɑltos]) is a city at the southern end of the San Francisco Peninsula, in the San Francisco Bay Area. The city is in Santa Clara County, California, United States. . The study is co-sponsored by Cyanotech's marketing partner in Japan, Kyowa Engineering Company. BioAstin is a proprietary formulation of the microalgae, Haematococcus pluvialis, which contains high levels of astaxanthin. Astaxanthin has been shown to be a potent antioxidant antioxidant, substance that prevents or slows the breakdown of another substance by oxygen. Synthetic and natural antioxidants are used to slow the deterioration of gasoline and rubber, and such antioxidants as vitamin C (ascorbic acid), butylated hydroxytoluene with over 550 times the strength of vitamin E and 10 times that of beta carotene. In a previous animal study, dietary astaxanthin significantly increased HDL cholesterol and decreased LDL cholesterol. The current study will test whether BioAstin can provide similar benefits to humans. "This is an exciting study on an important potential health benefit of BioAstin," said Gerald R. Cysewski, Ph.D., president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . "The US market for cholesterol-reducing drugs is in excess of $9 billion. If positive results are obtained from the clinical trial, we feel that there is a large market potential for a natural supplement that can reduce cholesterol." -- Cyanotech Corporation, the world's leader in microalgae technology, produces high-value natural products from microalgae, and is the world's largest commercial producer of natural astaxanthin (pronounced "asta-zan-thin") from microalgae. Products include BioAstin(TM) natural astaxanthin, a powerful antioxidant with expanding applications as a human nutraceutical; NatuRose(R) natural astaxanthin for the aquaculture aquaculture, the raising and harvesting of fresh- and saltwater plants and animals. The most economically important form of aquaculture is fish farming, an industry that accounts for an ever increasing share of world fisheries production. and animal feed industry; Spirulina spirulina Any cyanobacteria in the genus Spirulina. A traditional food source in parts of Africa and Mexico, spirulina is an exceptionally rich source of vitamins, minerals, and protein, and one of the few nonanimal sources of vitamin B12. Pacifica(R), a nutrient-rich dietary supplement; and phycobiliproteins, which are fluorescent pigments used in the immunological diagnostics market. Spirulina Pacifica and BioAstin are sold directly online through www.nutrex-hawaii.com and through resellers worldwide. Corporate and product information is available at www.cyanotech.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion